PMID: 41209547 References are provided for research reference only
Key Benefits of BPC 157 Injections Injectable delivery bypasses digestion and may allow for greater systemic exposure compared to oral forms
Several technical reasons may explain our distinctive findings, including differences in the microbiome sampling site, the limited n per group, singly housing mice, or the use of highly similar lean, Western, and high-fat diets which systematically exchanged fat content with carbohydrate content
Side effects are rare and typically limited to mild injection-site tenderness
The peptides tolerability profile was described as indistinguishable from placebo in most safety assessments
Symptoms may be generic and have overlap with other conditions, and therefore, be difficult to associate with a tickborne disease